Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06929234 | Effects of Health Education on Knowledge, Attitude and Screening for Cervical Cancer in Women | not yet recruiting | N/A | 30 | Ordu UniversityOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT06922903 | Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer. | not yet recruiting | Phase 3 | 240 | Yunhe Pharmaceutical (Tianjin) Co., LtdOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06925126 | Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer | not yet recruiting | — | 200 | Fudan UniversityOTHER | 0 | Apr 13, 2025 | clinicaltrials |
| NCT06921798 | Remote Resilience: Novel Applications of mHealth in Nicaragua's Cancer Control Program | not yet recruiting | N/A | 3,000 | University of VirginiaOTHER | 0 | Apr 10, 2025 | clinicaltrials |
| NCT06916013 | Focal Laser Ablation in Prostate Cancer | not yet recruiting | — | 30 | Ain Shams UniversityOTHER | 0 | Apr 8, 2025 | clinicaltrials |
| NCT06916117 | Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC | not yet recruiting | Phase 2 | 30 | RenJi HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06914427 | PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique | not yet recruiting | N/A | 35 | Xijing HospitalOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06911801 | In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer(FAPI_VULVA_1) | not yet recruiting | — | 90 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06828419 | A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery | not yet recruiting | N/A | 63 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06901778 | Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation | not yet recruiting | N/A | 106 | Peking University People's HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT05896371 | A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy(PRODIGY-1) | not yet recruiting | Phase 1 / Phase 2 | 500 | CHU de Quebec-Universite LavalOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06900348 | Prostate Specific Antigen Levels of Individuals Living in Rural Areas | not yet recruiting | — | 308 | Suleyman Demirel UniversityOTHER | 0 | Mar 30, 2025 | clinicaltrials |
| NCT06901492 | The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture | not yet recruiting | N/A | 120 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06882447 | A Study of QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer(QL1706) | not yet recruiting | Phase 2 | 35 | Northern Jiangsu People's HospitalOTHER | 0 | Mar 28, 2025 | clinicaltrials |
| NCT06890832 | A Study to Investigate Efficacy and Safety of Different Dose Regimen of Oral Cabazitaxel Tablet in Adult Participants with Prostate Cancer | not yet recruiting | Phase 2 | 75 | Jina Pharmaceuticals Inc.INDUSTRY | 0 | Mar 24, 2025 | clinicaltrials |
| NCT06875297 | A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients | not yet recruiting | N/A | 184 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06887933 | A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer | not yet recruiting | Phase 4 | 67 | GlaxoSmithKlineINDUSTRY | 0 | Mar 21, 2025 | clinicaltrials |
| NCT06887673 | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds | not yet recruiting | Early Phase 1 | 56 | University of South FloridaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06882473 | A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer | not yet recruiting | N/A | 20 | Peking University Third HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06870565 | Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma | not yet recruiting | Phase 3 | 238 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Mar 17, 2025 | clinicaltrials |
| NCT06871787 | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery(INOCA) | not yet recruiting | Phase 4 | 50 | Istanbul UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06878196 | ctDNA-guided First-line Immuno-de-escalation Therapy for IVB-stage and Recurrent Cervical Cancer | not yet recruiting | N/A | 20 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06866392 | Study on Novel Strategies for Cervical Cancer Screening Using Photoelectric Detection and Epigenetic Procotol(CC-AZ) | not yet recruiting | — | 4,200 | Peking Union Medical College HospitalOTHER | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06866795 | Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC) | not yet recruiting | Phase 1 | 42 | Geode Therapeutics Inc.INDUSTRY | 0 | Mar 10, 2025 | clinicaltrials |
| NCT06859151 | DNA Methylation and the Increased Risk of Cervical Cancer Development | not yet recruiting | — | 2,000 | Zhujiang HospitalOTHER | 0 | Mar 5, 2025 | clinicaltrials |
| NCT06855589 | Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.(PCS-XII) | not yet recruiting | Phase 3 | 400 | Charles LeMoyne HospitalOTHER | 1 | Mar 4, 2025 | clinicaltrials |
| NCT06846424 | SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer | not yet recruiting | Phase 1 | 24 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06844513 | Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform(URO-ROBOT-2023) | not yet recruiting | N/A | 800 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06838429 | PARPi and Ovarian Cancer Survival | not yet recruiting | — | 6,000 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 0 | Feb 20, 2025 | clinicaltrials |
| NCT06838520 | Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer | not yet recruiting | — | 200 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT06832397 | Detection of Peritoneal Metastases by Diagnostic LAparoscopy in Patients With Locally Advanced Cervical Carcinoma(SOLAR) | not yet recruiting | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT06827080 | Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 / Phase 2 | 15 | Zhengguo ChenOTHER | 0 | Feb 14, 2025 | clinicaltrials |
| NCT06828003 | Feasibility of a Remotely-Delivered Resistance Training Program for Cognitive Function in Men Living With and Beyond Prostate Cancer | not yet recruiting | N/A | 30 | University of TorontoOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06825455 | Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors | not yet recruiting | Early Phase 1 | 18 | Peking UniversityOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT06677242 | Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study(SEIC) | not yet recruiting | — | 100 | Erasmus Medical CenterOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06803381 | Somesthesia in Cancer Patients: Variability and Influence on Eating Experience(SOMEST'ALIM2) | not yet recruiting | — | 96 | Hospices Civils de LyonOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06813001 | ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study | not yet recruiting | N/A | 25 | Yonsei UniversityOTHER | 0 | Feb 6, 2025 | clinicaltrials |
| NCT06805864 | Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma(BROTHER) | not yet recruiting | Phase 2 | 45 | Gunma UniversityOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT05391243 | Large Loop Excision of the Transformation Zone During Follicular Vs. Luteal Phase of the Menstrual Cycle (LLETZ-MC)(LLETZ-MC) | not yet recruiting | N/A | 152 | Ruhr University of BochumOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT06304610 | Hospital-based Validation of the New ELEVATE Screening Tool(ELEVATE-Pilot) | not yet recruiting | N/A | 200 | University Hospital, GhentOTHER | 2 | Jan 27, 2025 | clinicaltrials |
| NCT06787807 | Proteomic Analysis of Patients Undergoing Bariatric Surgery | not yet recruiting | N/A | 103 | Universidade Federal de PernambucoOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06783153 | Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients | not yet recruiting | Phase 1 / Phase 2 | 80 | Mansoura UniversityOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06781216 | Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial Cancer | not yet recruiting | N/A | 66 | Akdeniz UniversityOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06777147 | Reproductive Health Outcomes in Young Patients With Ovarian Cancer After Surgical Treatment: A Retrospective Study | not yet recruiting | — | 50 | Assiut UniversityOTHER | 0 | Jan 15, 2025 | clinicaltrials |
| NCT06771154 | Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial(A-CAPE) | not yet recruiting | Phase 2 | 140 | Peking Union Medical College HospitalOTHER | 1 | Jan 13, 2025 | clinicaltrials |
| NCT06772116 | Focal Therapy in Localized Prostate Cancer: a Prospective Registry(JR) | not yet recruiting | — | 1,000 | Institut Mutualiste MontsourisOTHER | 0 | Jan 13, 2025 | clinicaltrials |
| NCT06768255 | Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC(mCRPC) | not yet recruiting | Phase 3 | 400 | Ding-Wei YeOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06762925 | Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment | not yet recruiting | — | 450 | Xijing HospitalOTHER | 0 | Jan 8, 2025 | clinicaltrials |
| NCT06760676 | A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy | not yet recruiting | Phase 1 | 90 | Anhui Provincial HospitalOTHER_GOV | 0 | Jan 7, 2025 | clinicaltrials |
| NCT06759480 | Study of Laparoscopic Radical Hysterectomy Based on Space Anatomy in Patients With IB3 and IIA2 Cervical Cancer | not yet recruiting | — | 500 | International Peace Maternity and Child Health HospitalOTHER | 0 | Jan 6, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Apr 16, 2025source: clinicaltrials